Table 1 Patient characteristics
Parameters | n = 208 |
|---|---|
 Median age when receiving HSCT, y (range) | 30 (4–57) |
 Gender | |
  Male | 124 (60%) |
  Female | 84 (40%) |
 c-KIT gene at diagnosis | |
  Mutation | 69 (33%) |
  Wild type | 80 (39%) |
  Unknown | 59 (28%) |
 First CR induction courses | |
  1 | 136 (65%) |
  >1 | 58 (28%) |
  Unknown | 14 (7%) |
 Interval between diagnosis and HSCT | |
  <8 months | 110 (53%) |
  ≥8 months | 98 (47%) |
 Disease status when receiving HSCT | |
  First CR | 179 (86%) |
  Second CR | 29 (14%) |
 Donor source | |
  HLA-matched sibling | 60 (29%) |
  Haploidentical | 135 (65%) |
  Unrelated donor | 10 (5.5%) |
  Cord blood | 1 (0.5%) |
 Conditioning regimen | |
  Chemotherapy based | 204 (98.1%) |
  TBI based | 4 (1.9%) |